\
&
Contact us
\
&
Contact us
Published on | 2 years ago
Programmes HealthThe aim of the oncNGS pre-commercial procurement (PCP) is to develop affordable integrated solutions that can completely transform cancer patients' experience through predictive diagnosis, prognosis and theranosis capabilities based on Next Generation Sequencing (NGS) technology. OncNGS invites entrepreneurs, start-ups, companies, academia, and other relevant stakeholders to present their proposal for designing, developing and testing their solution that will be provided during this PCP.
The oncNGS PCP Call for tender is now open. Deadline for submission is 17 October 2022.
All detailed information can be found on oncNGS' website.
Background information: The Horizon 2020 financed project 'OncNGS' is a strong consortium composed of 8 buyers from 5 EU Member States (Sciensano ; Institut Jules Bordet (Belgium) ; Institut Curie ; Hospices Civils de Lyon (France) ; Charite Universitaetsmedizin ; Ludwig Maximilians Universitaet Muenchen (Germany) ; Alleanza Contro il Cancro (Italy) ; Institut Catala d’Oncologia (Spain)) and supported by 6 entities with wide experience in their fields (Agència de Qualitat i Avaluació Sanitàries de Catalunya ; the Belgian Cancer Registry ; Institut National du Cancer ; Instituto de Investigación Biomédica de Salamanca ; Valle de Hebrón Instituto de Oncología ; De Clercq & Partners).
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities.
The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.
